Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 7
Author(s): G. Azizi
Affiliation:
Export Options
About this article
Cite this article as:
Azizi G. , Meet Our Editorial Board Member, Current Neuropharmacology 2020; 18 (7) . https://dx.doi.org/10.2174/1570159X1807200608124722
DOI https://dx.doi.org/10.2174/1570159X1807200608124722 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Protective Roles and Molecular Mechanisms of Troxerutin (Vitamin P4) for the Treatment of Chronic Diseases: A Mechanistic Review
Current Neuropharmacology CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study
Current Alzheimer Research Pharmacological Management of Huntingtons Disease: An Evidence- Based Review
Current Pharmaceutical Design Physical Exercise for the Treatment of Neuropsychiatric Disturbances in Alzheimer’s Dementia: Possible Mechanisms, Current Evidence and Future Directions
Current Alzheimer Research Molecular Biomarkers in Schizophrenia – Implications for Clinical Practice
Current Psychiatry Reviews Naturally Occurring Methyl Salicylate Glycosides
Mini-Reviews in Medicinal Chemistry Neuronal and Vascular Oxidative Stress in Alzheimers Disease
Current Neuropharmacology Prion-like Mechanisms in Alzheimer's Disease
Current Alzheimer Research Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents New Aspects of Cyclosporin A Mode of Action: from Gene Silencing to Gene Up-Regulation
Mini-Reviews in Medicinal Chemistry Role of Differential Signaling Pathways and Oxidative Stress in Diabetic Cardiomyopathy
Current Cardiology Reviews Harvesting New Therapeutic Avenues with Stem Cell Applications
Current Neurovascular Research Prepare and Assessment of a New Purity Certified Reference Material of Quercetin
Current Analytical Chemistry Resting-State Networks in Schizophrenia
Current Topics in Medicinal Chemistry Commentary ( Two Hits with One Shot – A Possibility of Simultaneous Targeting Motor Neuron Loss and Depression in ALS by Upregulating ADAR2 )
CNS & Neurological Disorders - Drug Targets Development of Doxorubicin Quantification by Reductive Amination
Current Analytical Chemistry Editorial [Hot topic: Developing New Anti-Cancer Drugs (Guest Editor: Ricardo De Souza Pereira)]
Recent Patents on Anti-Cancer Drug Discovery Energetics of Quadruplex-Drug Recognition in Anticancer Therapy
Current Cancer Drug Targets Association Between Oxidative Stress and Altered Cholesterol Metabolism in Alzheimer’s Disease Patients
Current Alzheimer Research Selective Inhibition of Neuronal Nitric Oxide Synthase by L-Arginine Derivatives
Letters in Drug Design & Discovery